Announcement for the National Registry of Evidence-Based Programs and Practices (NREPP): Open Submission Period for Fiscal Year 2014, 33853-33855 [2013-13223]
Download as PDF
Federal Register / Vol. 78, No. 108 / Wednesday, June 5, 2013 / Notices
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Trauma and Hemostasis.
Date: June 25, 2013.
Time: 7:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Crystal Gateway Marriott, 1700
Jefferson Davis Highway, Arlington, VA
22202.
Contact Person: Michael P Reilly, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7200, Bethesda, MD 20892, 301–496–9659,
reillymp@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Short-term Training to Promote Diversity in
Health Research.
Date: June 27, 2013.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Room 7189, Bethesda, MD
20892, (Telephone Conference Call).
Contact Person: Stephanie L Constant,
Ph.D., Scientific Review Officer, Office of
Scientific Review/DERA, National Heart,
Lung, and Blood Institute, 6701 Rockledge
Drive, Room 7189, Bethesda, MD 20892, 301–
443–8784, constantsl@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: May 30, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Spinal cord
biology and bone implants.
Date: June 27, 2013.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call).
Contact Person: Priscilla B. Chen, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4104,
MSC 7814, Bethesda, MD 20892, (301) 435–
1787, chenp@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Molecular Genetic Mechanisms.
Date: July 3, 2013.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Dominique Lorang-Leins,
Ph.D., Scientific Review Officer, National
Institutes of Health, Center for Scientific
Review, 6701 Rockledge Drive, Room 5108,
MSC 7766, Bethesda, MD 20892,
301.326.9721, Lorangd@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 30, 2013.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–13263 Filed 6–4–13; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2013–13264 Filed 6–4–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
33853
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; PAR
11–109 Grand Opportunity in Medications
Development for Substance-Related
Disorders.
Date: June 20, 2013.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Jose F. Ruiz, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, NIH, Room 4228, MSC 9550,
6001 Executive Blvd., Bethesda, MD 20892–
9550, (301) 451–3086, ruizjf@nida.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Exceptional Unconventional Research
Enabling Knowledge Acceleration (EUREKA)
for Neuroscience and Disorders of the
Nervous System (R01).
Date: July 22, 2013.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: Minna Liang, Ph.D.,
Scientific Review Officer, Grants Review
Branch, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, 6001 Executive Blvd., Room 4226,
MSC 9550, Bethesda, MD 20892–9550, 301–
435–1432, liangm@nida.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos.: 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: May 30, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–13265 Filed 6–4–13; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Center for Scientific Review; Notice of
Closed Meetings
mstockstill on DSK4VPTVN1PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 USC,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
Substance Abuse and Mental Health
Services Administration (SAMHSA)
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
VerDate Mar<15>2010
16:43 Jun 04, 2013
Jkt 229001
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Announcement for the National
Registry of Evidence-Based Programs
and Practices (NREPP): Open
Submission Period for Fiscal Year
2014
SAMHSA, Health and Human
Services.
ACTION: Announcement.
AGENCY:
SUMMARY: The mission of SAMHSA is to
reduce the impact of substance abuse
E:\FR\FM\05JNN1.SGM
05JNN1
33854
Federal Register / Vol. 78, No. 108 / Wednesday, June 5, 2013 / Notices
and mental illness on America’s
communities. Established in 1992, the
Agency was directed by Congress to
target effective substance abuse and
mental health services to the people
most in need and to translate research
in these areas more effectively and more
rapidly into the general health care
system. NREPP is a key public resource
SAMHSA has developed to help meet
this directive. As of June 2013,
approximately 290 interventions
developed in the U.S. and abroad have
been reviewed and added to the registry.
This notice announces NREPP’s open
submission period for fiscal year 2014,
during which program developers may
submit a request to have their
intervention reviewed. The notice
provides information about the
documentation that submissions must
include to demonstrate that an
intervention meets NREPP’s minimum
requirements; the responsibilities of the
Principal during the review process; and
the process for submitting materials for
review during the open submission
period.
FOR FURTHER INFORMATION CONTACT:
Alyson Essex, Ph.D., MHS, Social
Science Analyst, SAMHSA, 1 Choke
Cherry Road, Room 2–1002, Rockville,
MD 20857, telephone 240–276–0529.
Substance Abuse and Mental Health
Services Administration’s National
Registry of Evidence-Based Programs
and Practices (NREPP): Open
Submission Period for Fiscal Year 2014
Background
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA) National Registry of
Evidence-based Programs and Practices
(NREPP) is a searchable online database
of interventions that have been shown
to produce significant behavioral
outcomes in substance abuse
prevention, mental health promotion, or
the treatment of mental or substance
abuse disorders and that are ready to be
implemented by the public.
Interventions that are accepted for
review by NREPP undergo an
independent review process in which
(1) up to three studies are assessed and
rated for Quality of Research and (2) the
intervention’s implementation, training,
and quality assurance materials and
processes are assessed and rated for
Readiness for Dissemination. The
results of these reviews are published
on the NREPP Web site, https://
nrepp.samhsa.gov. NREPP is designed
as a decision-support tool for providers
responsible for selecting and
implementing interventions. The
acceptance of interventions for review
and the inclusion of interventions on
the NREPP Web site are not intended to
convey endorsement, recommendation,
or approval of these interventions by
SAMHSA. Policymakers and funders, in
particular, are discouraged from
requiring contracted providers or
grantees to use specific interventions
based on their inclusion in the registry.
This notice announces the next open
submission period during which
SAMHSA will consider and accept
requests for review, describes the
requirements for submission, and
provides information about the review
process.
Open Submission Period
SAMHSA has established a 2-month
period for receipt of requests for NREPP
reviews for fiscal year 2014 that will
begin January 2, 2014, and end February
28, 2014. Submitters are encouraged to
visit the NREPP Web site to learn more
about the review process. The Reviews
& Submissions page (https://
nrepp.samhsa.gov/Reviews.aspx)
provides an overview of the steps
involved in reviews, the rating criteria
used to assess Quality of Research and
Readiness for Dissemination, and how
reviewers are selected and trained.
Examples of published intervention
summaries, the end product of each
review, can be viewed at https://
nrepp.samhsa.gov/ViewAll.aspx.
Minimum Requirements
For an intervention to be eligible for
review, the submitter must provide
written documentation that
demonstrates the following minimum
requirements have been met:
1. The intervention has produced one
or more positive behavioral outcomes
(p≤.05) in mental health or substance
abuse among individuals, communities,
or populations. Significant differences
between groups over time must be
demonstrated for each outcome.
2. Evidence of the positive behavioral
outcome(s) has been demonstrated in at
least one study using an experimental or
quasi-experimental design.
Experimental designs include random
assignment of participants, a control or
comparison group in addition to the
intervention group, and pre- and
posttest assessments. Quasiexperimental designs include a control
or comparison group and pre-and
posttest assessments but do not use
random assignment. Studies with
single-group, pretest/posttest designs do
not meet this requirement.
3. The results of these studies have
been published in a peer-reviewed
journal or other professional publication
(e.g., a book volume) or documented in
a comprehensive evaluation report.
Comprehensive evaluation reports must
include the following sections or their
equivalent: a review of the literature,
theoretical framework, purpose,
methodology, findings/results (with
statistical analysis and p values for
significant outcomes), discussion, and
conclusions. Information must be
included to enable rating of the six
Quality of Research criteria: (1)
Reliability of measures, (2) validity of
measures, (3) intervention fidelity, (4)
missing data and attrition, (5) potential
confounding variables, and (6)
appropriateness of analysis.
4. Implementation materials, training
and support resources, and quality
assurance procedures have been
developed and are ready for use by the
public.
The documentation demonstrating
these minimum requirements must be
provided at the time of submission.
Table 1 lists examples of appropriate
supporting documentation.
TABLE 1—DOCUMENTATION FOR DEMONSTRATING SATISFACTION OF MINIMUM REQUIREMENTS
mstockstill on DSK4VPTVN1PROD with NOTICES
Minimum requirement
Documentation
Quality of Research:
1. Intervention has produced one or more positive behavioral out- A list of significant behavioral outcomes that includes supporting citacomes (p≤.05) in mental health or substance abuse among inditions (document/page number) for the location of each outcome
viduals, communities, or populations. Significant differences beshowing p values and
tween groups over time must be demonstrated for each outcome.
2. Evidence of these outcomes has been demonstrated in at least A full-text copy of each article/report cited in the list of outcomes. Other
one study using an experimental or quasi-experimental design.
research articles, published or unpublished evaluation reports, grant
final reports, and replication studies may be submitted as additional
supporting documentation.
VerDate Mar<15>2010
16:43 Jun 04, 2013
Jkt 229001
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
E:\FR\FM\05JNN1.SGM
05JNN1
Federal Register / Vol. 78, No. 108 / Wednesday, June 5, 2013 / Notices
33855
TABLE 1—DOCUMENTATION FOR DEMONSTRATING SATISFACTION OF MINIMUM REQUIREMENTS—Continued
Minimum requirement
Documentation
3. Results of these studies have been published in a peer-reviewed journal or other professional publication (e.g. book volume) or documented in a comprehensive evaluation report.
Readiness for Dissemination:
4. Implementation materials, training and support resources, and
quality assurance procedures have been developed and are
ready for use by the public.
Ineligible Interventions
The following types of interventions
are not eligible for review:
1. Stand-alone pharmacologic
treatments. The evidence base for
pharmacologic treatments is reviewed
and approved through the U.S. Food
and Drug Administration (FDA). FDAapproved pharmacotherapy
interventions (on-label use) are
considered for NREPP review only
when combined with one or more
behavioral or psychosocial treatments.
2. Interventions that have been
developed or evaluated with funds or
other support, either partially or wholly,
from organizations whose goals or
activities are determined to be
inconsistent with SAMHSA’s mission.
mstockstill on DSK4VPTVN1PROD with NOTICES
Acceptance of Interventions
Submissions that meet the four
minimum requirements (excluding
ineligible interventions previously
noted) will be considered for review.
The number of interventions selected by
SAMHSA for review and the timing of
these reviews depend on the availability
of funds and will be determined at
SAMHSA’s discretion. Interventions not
selected for review during this fiscal
year may be resubmitted during a future
open submission period.
Role of the Principal
Before an intervention can be formally
accepted for review and added to the
Accepted for Review list on the NREPP
Web site, there must be agreement upon
and designation by the submitting
organization of a Principal to oversee
the review. The designation of the
Principal role must be agreed to by
those who have had a major role in the
development and/or evaluation of the
intervention. The Principal is typically
a principal investigator who has
conducted research on the intervention,
VerDate Mar<15>2010
16:43 Jun 04, 2013
Jkt 229001
Documentation must be provided to enable the rating of the six Quality
of Research criteria (i.e., reliability of measures, validity of measures,
intervention fidelity, missing data and attrition, potential confounding
variables, and appropriateness of analysis).
NOTE: Abstracts or URLs to partial articles are regarded as incomplete
documentation and will not be considered. Meta-analyses will not be
considered for review.
A brief narrative description and list of available materials, resources,
and systems to support implementation (e.g., treatment manuals, information for administrators, tested training curricula, mechanisms for
ongoing supervision and consultation, protocols for gathering process and outcome data, ongoing monitoring of intervention fidelity,
processes for gathering feedback) and
A brief description of the method through which new implementation
sites acquire the above materials.
a program developer who has
collaborated with an evaluator of the
intervention, or an official of the
organization requesting the review.
The Principal is responsible for
ensuring provision of all materials and
documentation to be used in the review.
This includes full-text copies of articles
and reports that provide evidence of
significant outcomes as well as copies of
dissemination materials in the format
they are provided to the public (e.g.,
hard copies or electronic versions of
manuals, training presentations, tools,
quality assurance protocols, URLs for
interactive Web-based resources). The
Principal is required to participate in a
kickoff call at the commencement of
review and may be asked to answer
questions about the intervention, the
articles, or the intervention materials for
clarification at various points
throughout the review process.
At the end of the review, the Principal
receives a draft intervention summary
presenting the results of the review and
is asked to provide corrections and
comments. The results of NREPP
reviews are considered public, and after
having the opportunity to comment on
the summary, the Principal is expected
to authorize publication of the summary
on the NREPP Web site. If the Principal
does not provide that authorization, the
intervention will be identified on the
NREPP Web site as having undergone
review, with a statement indicating the
Principal did not authorize publication
of the summary.
submitted electronically using an online
submission tool that will be made
available during the open submission
period. On January 2, 2014, NREPP will
post a link to the online submission tool
and instructions for how to obtain a
username and password at https://www.
nrepp.samhsa.gov/ReviewSubmission.
aspx. Please call 1–866–436–7377 for
technical assistance on the electronic
submission process or to arrange for
submission by hard copy or fax if
electronic submission is not possible.
To be eligible for consideration, a
complete submission including both the
letter of request and supporting
documents must be received no later
than 11:59 p.m. E.S.T. on February 28,
2014; materials received before January
2, 2014, will be disregarded.
FOR FURTHER INFORMATION CONTACT:
Individuals who have specific questions
about the information contained in this
notice may write to NREPP staff at
nrepp@samhsa.hhs.gov or call 1–866–
436–7377.
Instructions for Submitting an
Intervention
Submissions must include (1) a letter
formally requesting a review and (2)
documentation demonstrating that the
minimum requirements described above
have been met. NREPP prefers letters of
interest and supporting materials to be
Merchant Mariner Medical Advisory
Committee: Intercessional Meeting
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Summer King,
Statistician.
[FR Doc. 2013–13223 Filed 6–4–13; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2011–0138]
Coast Guard, DHS.
Notice of Federal Advisory
Committee Working Group Meeting.
AGENCY:
ACTION:
SUMMARY: Two working groups of the
Merchant Mariner Medical Advisory
E:\FR\FM\05JNN1.SGM
05JNN1
Agencies
[Federal Register Volume 78, Number 108 (Wednesday, June 5, 2013)]
[Notices]
[Pages 33853-33855]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-13223]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration (SAMHSA)
Announcement for the National Registry of Evidence-Based Programs
and Practices (NREPP): Open Submission Period for Fiscal Year 2014
AGENCY: SAMHSA, Health and Human Services.
ACTION: Announcement.
-----------------------------------------------------------------------
SUMMARY: The mission of SAMHSA is to reduce the impact of substance
abuse
[[Page 33854]]
and mental illness on America's communities. Established in 1992, the
Agency was directed by Congress to target effective substance abuse and
mental health services to the people most in need and to translate
research in these areas more effectively and more rapidly into the
general health care system. NREPP is a key public resource SAMHSA has
developed to help meet this directive. As of June 2013, approximately
290 interventions developed in the U.S. and abroad have been reviewed
and added to the registry. This notice announces NREPP's open
submission period for fiscal year 2014, during which program developers
may submit a request to have their intervention reviewed. The notice
provides information about the documentation that submissions must
include to demonstrate that an intervention meets NREPP's minimum
requirements; the responsibilities of the Principal during the review
process; and the process for submitting materials for review during the
open submission period.
FOR FURTHER INFORMATION CONTACT: Alyson Essex, Ph.D., MHS, Social
Science Analyst, SAMHSA, 1 Choke Cherry Road, Room 2-1002, Rockville,
MD 20857, telephone 240-276-0529.
Substance Abuse and Mental Health Services Administration's National
Registry of Evidence-Based Programs and Practices (NREPP): Open
Submission Period for Fiscal Year 2014
Background
The Substance Abuse and Mental Health Services Administration's
(SAMHSA) National Registry of Evidence-based Programs and Practices
(NREPP) is a searchable online database of interventions that have been
shown to produce significant behavioral outcomes in substance abuse
prevention, mental health promotion, or the treatment of mental or
substance abuse disorders and that are ready to be implemented by the
public. Interventions that are accepted for review by NREPP undergo an
independent review process in which (1) up to three studies are
assessed and rated for Quality of Research and (2) the intervention's
implementation, training, and quality assurance materials and processes
are assessed and rated for Readiness for Dissemination. The results of
these reviews are published on the NREPP Web site, https://nrepp.samhsa.gov. NREPP is designed as a decision-support tool for
providers responsible for selecting and implementing interventions. The
acceptance of interventions for review and the inclusion of
interventions on the NREPP Web site are not intended to convey
endorsement, recommendation, or approval of these interventions by
SAMHSA. Policymakers and funders, in particular, are discouraged from
requiring contracted providers or grantees to use specific
interventions based on their inclusion in the registry.
This notice announces the next open submission period during which
SAMHSA will consider and accept requests for review, describes the
requirements for submission, and provides information about the review
process.
Open Submission Period
SAMHSA has established a 2-month period for receipt of requests for
NREPP reviews for fiscal year 2014 that will begin January 2, 2014, and
end February 28, 2014. Submitters are encouraged to visit the NREPP Web
site to learn more about the review process. The Reviews & Submissions
page (https://nrepp.samhsa.gov/Reviews.aspx) provides an overview of the
steps involved in reviews, the rating criteria used to assess Quality
of Research and Readiness for Dissemination, and how reviewers are
selected and trained. Examples of published intervention summaries, the
end product of each review, can be viewed at https://nrepp.samhsa.gov/ViewAll.aspx.
Minimum Requirements
For an intervention to be eligible for review, the submitter must
provide written documentation that demonstrates the following minimum
requirements have been met:
1. The intervention has produced one or more positive behavioral
outcomes (p<=.05) in mental health or substance abuse among
individuals, communities, or populations. Significant differences
between groups over time must be demonstrated for each outcome.
2. Evidence of the positive behavioral outcome(s) has been
demonstrated in at least one study using an experimental or quasi-
experimental design. Experimental designs include random assignment of
participants, a control or comparison group in addition to the
intervention group, and pre- and posttest assessments. Quasi-
experimental designs include a control or comparison group and pre-and
posttest assessments but do not use random assignment. Studies with
single-group, pretest/posttest designs do not meet this requirement.
3. The results of these studies have been published in a peer-
reviewed journal or other professional publication (e.g., a book
volume) or documented in a comprehensive evaluation report.
Comprehensive evaluation reports must include the following sections or
their equivalent: a review of the literature, theoretical framework,
purpose, methodology, findings/results (with statistical analysis and p
values for significant outcomes), discussion, and conclusions.
Information must be included to enable rating of the six Quality of
Research criteria: (1) Reliability of measures, (2) validity of
measures, (3) intervention fidelity, (4) missing data and attrition,
(5) potential confounding variables, and (6) appropriateness of
analysis.
4. Implementation materials, training and support resources, and
quality assurance procedures have been developed and are ready for use
by the public.
The documentation demonstrating these minimum requirements must be
provided at the time of submission. Table 1 lists examples of
appropriate supporting documentation.
Table 1--Documentation for Demonstrating Satisfaction of Minimum
Requirements
------------------------------------------------------------------------
Minimum requirement Documentation
------------------------------------------------------------------------
Quality of Research:
1. Intervention has produced one or A list of significant
more positive behavioral outcomes behavioral outcomes that
(p<=.05) in mental health or includes supporting citations
substance abuse among individuals, (document/page number) for the
communities, or populations. location of each outcome
Significant differences between showing p values and
groups over time must be
demonstrated for each outcome.
2. Evidence of these outcomes has A full-text copy of each
been demonstrated in at least one article/report cited in the
study using an experimental or list of outcomes. Other
quasi-experimental design. research articles, published
or unpublished evaluation
reports, grant final reports,
and replication studies may be
submitted as additional
supporting documentation.
[[Page 33855]]
3. Results of these studies have Documentation must be provided
been published in a peer-reviewed to enable the rating of the
journal or other professional six Quality of Research
publication (e.g. book volume) or criteria (i.e., reliability of
documented in a comprehensive measures, validity of
evaluation report. measures, intervention
fidelity, missing data and
attrition, potential
confounding variables, and
appropriateness of analysis).
NOTE: Abstracts or URLs to
partial articles are regarded
as incomplete documentation
and will not be considered.
Meta-analyses will not be
considered for review.
Readiness for Dissemination:
4. Implementation materials, A brief narrative description
training and support resources, and list of available
and quality assurance procedures materials, resources, and
have been developed and are ready systems to support
for use by the public. implementation (e.g.,
treatment manuals, information
for administrators, tested
training curricula, mechanisms
for ongoing supervision and
consultation, protocols for
gathering process and outcome
data, ongoing monitoring of
intervention fidelity,
processes for gathering
feedback) and
A brief description of the
method through which new
implementation sites acquire
the above materials.
------------------------------------------------------------------------
Ineligible Interventions
The following types of interventions are not eligible for review:
1. Stand-alone pharmacologic treatments. The evidence base for
pharmacologic treatments is reviewed and approved through the U.S. Food
and Drug Administration (FDA). FDA-approved pharmacotherapy
interventions (on-label use) are considered for NREPP review only when
combined with one or more behavioral or psychosocial treatments.
2. Interventions that have been developed or evaluated with funds
or other support, either partially or wholly, from organizations whose
goals or activities are determined to be inconsistent with SAMHSA's
mission.
Acceptance of Interventions
Submissions that meet the four minimum requirements (excluding
ineligible interventions previously noted) will be considered for
review. The number of interventions selected by SAMHSA for review and
the timing of these reviews depend on the availability of funds and
will be determined at SAMHSA's discretion. Interventions not selected
for review during this fiscal year may be resubmitted during a future
open submission period.
Role of the Principal
Before an intervention can be formally accepted for review and
added to the Accepted for Review list on the NREPP Web site, there must
be agreement upon and designation by the submitting organization of a
Principal to oversee the review. The designation of the Principal role
must be agreed to by those who have had a major role in the development
and/or evaluation of the intervention. The Principal is typically a
principal investigator who has conducted research on the intervention,
a program developer who has collaborated with an evaluator of the
intervention, or an official of the organization requesting the review.
The Principal is responsible for ensuring provision of all
materials and documentation to be used in the review. This includes
full-text copies of articles and reports that provide evidence of
significant outcomes as well as copies of dissemination materials in
the format they are provided to the public (e.g., hard copies or
electronic versions of manuals, training presentations, tools, quality
assurance protocols, URLs for interactive Web-based resources). The
Principal is required to participate in a kickoff call at the
commencement of review and may be asked to answer questions about the
intervention, the articles, or the intervention materials for
clarification at various points throughout the review process.
At the end of the review, the Principal receives a draft
intervention summary presenting the results of the review and is asked
to provide corrections and comments. The results of NREPP reviews are
considered public, and after having the opportunity to comment on the
summary, the Principal is expected to authorize publication of the
summary on the NREPP Web site. If the Principal does not provide that
authorization, the intervention will be identified on the NREPP Web
site as having undergone review, with a statement indicating the
Principal did not authorize publication of the summary.
Instructions for Submitting an Intervention
Submissions must include (1) a letter formally requesting a review
and (2) documentation demonstrating that the minimum requirements
described above have been met. NREPP prefers letters of interest and
supporting materials to be submitted electronically using an online
submission tool that will be made available during the open submission
period. On January 2, 2014, NREPP will post a link to the online
submission tool and instructions for how to obtain a username and
password at https://www.nrepp.samhsa.gov/ReviewSubmission.aspx. Please
call 1-866-436-7377 for technical assistance on the electronic
submission process or to arrange for submission by hard copy or fax if
electronic submission is not possible. To be eligible for
consideration, a complete submission including both the letter of
request and supporting documents must be received no later than 11:59
p.m. E.S.T. on February 28, 2014; materials received before January 2,
2014, will be disregarded.
FOR FURTHER INFORMATION CONTACT: Individuals who have specific
questions about the information contained in this notice may write to
NREPP staff at nrepp@samhsa.hhs.gov or call 1-866-436-7377.
Summer King,
Statistician.
[FR Doc. 2013-13223 Filed 6-4-13; 8:45 am]
BILLING CODE 4162-20-P